192 related articles for article (PubMed ID: 21259250)
21. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
22. Role of postoperative irradiation for patients with bilateral cervical nodal metastases from cutaneous melanoma: a critical assessment.
Guadagnolo BA; Myers JN; Zagars GK
Head Neck; 2010 Jun; 32(6):708-13. PubMed ID: 19787786
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?
Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF
Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539
[TBL] [Abstract][Full Text] [Related]
24. A glimpse of future management of melanoma.
Cochran AJ
Arch Dermatol; 2009 Oct; 145(10):1176-7. PubMed ID: 19841407
[No Abstract] [Full Text] [Related]
25. Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective.
Queirolo P; Taveggia P; Gipponi M; Sertoli MR
J Surg Oncol; 2004 Mar; 85(3):162-5. PubMed ID: 14991888
[TBL] [Abstract][Full Text] [Related]
26. Lymph node ratio provides prognostic information in addition to american joint committee on cancer N stage in patients with melanoma, even if quality of surgery is standardized.
Spillane AJ; Cheung BL; Winstanley J; Thompson JF
Ann Surg; 2011 Jan; 253(1):109-15. PubMed ID: 21119509
[TBL] [Abstract][Full Text] [Related]
27. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
[TBL] [Abstract][Full Text] [Related]
28. Melanoma metastases to the neck nodes: role of adjuvant irradiation.
Strojan P; Jancar B; Cemazar M; Perme MP; Hocevar M
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1039-45. PubMed ID: 19910139
[TBL] [Abstract][Full Text] [Related]
29. Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma.
Lee CC; Faries MB; Wanek LA; Morton DL
J Clin Oncol; 2008 Feb; 26(4):535-41. PubMed ID: 18235114
[TBL] [Abstract][Full Text] [Related]
30. The evolution of the management of regional lymph nodes in melanoma.
Landry CS; McMasters KM; Scoggins CR
J Surg Oncol; 2007 Sep; 96(4):316-21. PubMed ID: 17879333
[TBL] [Abstract][Full Text] [Related]
31. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
[TBL] [Abstract][Full Text] [Related]
32. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
Scoggins CR; Bowen AL; Martin RC; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; Hagendoorn L; McMasters KM
Arch Surg; 2010 Jul; 145(7):622-7. PubMed ID: 20644123
[TBL] [Abstract][Full Text] [Related]
33. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
35. Short-term morbidity associated with sentinel lymph node biopsy in cutaneous malignant melanoma.
Ling A; Dawkins R; Bailey M; Leung M; Cleland H; Serpell J; Kelly J
Australas J Dermatol; 2010 Feb; 51(1):13-7. PubMed ID: 20148833
[TBL] [Abstract][Full Text] [Related]
36. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
[TBL] [Abstract][Full Text] [Related]
37. [Extent of the surgical intervention in regional metastases of melanomas of the head and neck].
Vagner RI; Valdina EA; Anisimov VV
Vestn Khir Im I I Grek; 1987 Jan; 138(1):43-6. PubMed ID: 3590534
[TBL] [Abstract][Full Text] [Related]
38. Incidence and survival of desmoplastic melanoma in the United States, 1992-2007.
Feng Z; Wu X; Chen V; Velie E; Zhang Z
J Cutan Pathol; 2011 Aug; 38(8):616-24. PubMed ID: 21518379
[TBL] [Abstract][Full Text] [Related]
39. The value of sentinel node biopsy in patients with primary cutaneous melanoma.
Thompson JF
Dermatol Surg; 2008 Apr; 34(4):550-4; discussion 554-5. PubMed ID: 18261107
[No Abstract] [Full Text] [Related]
40. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
